Results 101 to 110 of about 781,795 (221)

A study showing efficacy of harmonic scalpel over electrocautery in modified radical mastectomy

open access: yes, 2017
Background: The dissection in breast surgeries can be done using sharp scalpel and scissor dissection and high frequency electrocautery. Rarely, radiofrequency ablation and laser had been used in some limited trails. This study aims to prove the efficacy
Praveen P. Nair   +2 more
core   +1 more source

Comparison of outcomes of Nylon and Silk sutures two weeks post modified radical mastectomy

open access: yes
AIM: To study the outcomes of nylon and silk sutures for skin closure two weeks post modified radical mastectomy. OBJECTIVES: 1: To assess postoperative complications, cosmetic appearance and surgical site infection of wound in modified radical ...
Dayal, Arshiya   +3 more
core   +1 more source

Local Recurrence in the Pectoralis Major Muscle Following Modified Radical Mastectomy for Breast Cancer [PDF]

open access: yes, 1997
Local recurrence in the pectoralis muscle after modified radical mastectomy for breast cancer is rare. We encountered a 53-year-old woman who developed a small nodule on her right antero-lateral chest wall after modified radical mastectomy.
Akamine, Shinji   +7 more
core   +2 more sources

An Update on Early‐Onset Breast Cancer: Incidence, Risk Factors, Genetic Testing, and Treatment

open access: yesComputational and Systems Oncology, Volume 6, Issue 1, December 2026.
ABSTRACT Early‐onset breast cancer presents in patients typically under the age of 40, while very early‐onset breast cancer is usually viewed as breast cancer occurring before the age of 35. Early‐onset breast cancer demonstrates specific molecular properties and has worse outcomes compared to its late‐onset breast cancer counterpart.
Leila Jahangiri
wiley   +1 more source

De‐Escalation of Neoadjuvant Treatment for HER2‐Positive Breast Cancer

open access: yesInternational Journal of Cancer, Volume 159, Issue 10, Page 2393-2402, 15 November 2026.
ABSTRACT With improved prognosis in early HER2‐positive breast cancer, safely de‐escalating treatment is increasingly investigated to minimize overtreatment. This article focuses on neoadjuvant de‐escalation strategies for HER2‐positive breast cancer.
Yiyin Ma, Dedian Chen, Sheng Huang
wiley   +1 more source

Defining priorities for care among young adults diagnosed with breast cancer

open access: yesPediatric, Adolescent &Young Adult Cancer, Volume 1, Issue 1, November 2026.
Abstract Introduction Breast cancer is a leading cause of cancer‐related mortality among young adults (YAs) aged 18–39 years. Although the National Comprehensive Cancer Network recommends that YAs be treated at centers with age‐specific expertise, standardized care pathways are lacking.
Caroline Lommer   +9 more
wiley   +1 more source

Hemorrhagic Invasive Ductal Carcinoma with Immunohistological Expression of Beta-subunit HCG : A Case Report

open access: yesSiriraj Medical Journal, 2020
A hemorrhagic breast mass was excised from a 27-year-old female. Microscopically, the tumor showed typical areas of invasive ductal carcinoma with intraductal component admixed with some trophoblast-like tumor giant cells in the hemorrhagic area.
Piyavadee Leksrisakul   +6 more
doaj  

Breast Cancer Outcomes From Ductal Carcinoma In Situ: A Population‐Based Cohort Study

open access: yesInternational Journal of Cancer, Volume 159, Issue 8, Page 1917-1927, 15 October 2026.
Women with ductal carcinoma in situ have an elevated risk of subsequent invasive breast cancer, but how this risk evolves over time is unclear. In this population‐based study of ethnically diverse women diagnosed between 2000 and 2022 in New Zealand, the risk of invasive ipsilateral breast cancer persisted beyond 5 years.
Qian Chen   +5 more
wiley   +1 more source

Effectiveness criteria of early rehabilitative treatment of patients with postoperative upper plexopathy [PDF]

open access: yesСаратовский научно-медицинский журнал, 2017
The damage of the peripheral nervous system often acts as a complication of extensive surgical interventions on the removal of malignant breast tumors. The research goal is to evaluate the criteria for the effectiveness of early rehabilitation treatment ...
Tosheva M.l.   +2 more
doaj  

Exceptional Locoregional Pathological Response in Metastatic Triple‐Negative Breast Cancer Treated With Palliative Platinum‐Based Chemotherapy

open access: yesClinical Case Reports, Volume 14, Issue 10, October 2026.
ABSTRACT Locoregional pathological complete response with concurrent radiologic metabolic remission following palliative gemcitabine–carboplatin chemotherapy in young, low‐grade metastatic triple‐negative breast cancer patient suggests potential chemosensitivity in select advanced cases, warranting further clinical investigation.
Shristi Gupta   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy